Equinom - Gil Shalev

Gil Shalev ©Equinom

Interviews

Equinom: “We Simply Need to Make the Most of the Wonders That Nature Has Designed Over Millions of Years”

Israel’s Equinom is a company with a clear mission: to ensure the supply of nutritious and affordable alt proteins for a sustainable future. This year, the company celebrated a $20 million Series C funding round to help achieve that goal. Developing AI and plant breeding techniques to produce improved seeds without the use of genetic modification, Equinom has been involved in a host of partnerships recently, including for Black Sheep Foods’ plant-based lamb, as well as Meatless Farm and Europe’s largest milling company GoodMills. We talked with Founder and CEO Gil Shalev about the company and its work with various high profile partners in the field to assist the acceleration of plant-based. Please introduce EQINOM and its mission Equinom is a food-tech company combining agricultural know-how, …

more

BH_Soybean

© Benson Hill

Agriculture / Agribusiness

Benson Hill Announces ‘Crop Accelerator’ to Supply Massive Demand for Plant Meat

Benson Hill, a publicly listed company since this September, announces the opening of its Crop Accelerator, a state-of-the-art research facility located near the Company’s St. Louis HQ. The company reports that the Crop Accelerator, designed to provide a more than twenty-fold expansion in testing capacity, is operational ahead of schedule and that its first soybean and yellow pea seeds were planted on September 17. The Crop Accelerator employs 27 staff and is looking to hire more innovators in plant science, data science and food science as it continues its expansion to meet demand for such ingredients, as the plant-based meat market is forecast to reach approximately $140 billion by 2029.  The 47,000 square-foot facility features dynamically adaptive Conviron® growth houses and chambers, equipped with multi-channel LEDs, additive CO2, temperature, humidity and …

more

Benson Hill

© Benson Hill

Agriculture / Agribusiness

What Benson Hill’s $2B Public Valuation Means for Alt Protein

Benson Hill plans to go public in a merger with a special-purpose acquisition company (SPAC) in a deal valuing the St. Louis-based plant-tech firm at $2 billion. Benson Hill is developing gene-edited and selectively bred versions of crops used in alt protein products, with the deal’s expected $625 million capital raise accelerating Benson Hill’s ability to drive down plant-based food costs.  With the commercial production of its ultrahigh-protein soybean and yellow-pea protein concentrate set to begin next year, Benson Hill says it can develop soy and pea crop breeds that mature faster, have higher protein content, or taste better, thus saving time and resources in the production of alt protein products. SPACs are shell companies that raise funds through an IPO to take a private …

more